0001209191-22-051466.txt : 20220928
0001209191-22-051466.hdr.sgml : 20220928
20220928164751
ACCESSION NUMBER: 0001209191-22-051466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220926
FILED AS OF DATE: 20220928
DATE AS OF CHANGE: 20220928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gandhi Mayank
CENTRAL INDEX KEY: 0001832725
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39866
FILM NUMBER: 221276668
MAIL ADDRESS:
STREET 1: 628 MIDDLEFIELD ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc.
CENTRAL INDEX KEY: 0001828522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853306396
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: (858) 925-8215
MAIL ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER COMPANY:
FORMER CONFORMED NAME: Locust Walk Acquisition Corp.
DATE OF NAME CHANGE: 20201015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-26
0
0001828522
eFFECTOR Therapeutics, Inc.
EFTR
0001832725
Gandhi Mayank
C/O EFFECTOR THERAPEUTICS, INC.
142 NORTH CEDROS AVENUE, SUITE B
SOLANA BEACH
CA
92075
0
1
0
0
Chief Business Officer
Stock Option (Right to Buy)
0.565
2022-09-26
4
A
0
500000
0.00
A
2032-09-25
Common Stock
500000
500000
D
The stock option vests 25% on September 26, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Michael Byrnes, Attorney-in-Fact for Mayank Gandhi
2022-09-28